Whistleblower gets $250m as Biogen settles US kickbacks case
pharmaphorum
SEPTEMBER 27, 2022
Biogen has finalised a $900 million payment to settle a whistleblower lawsuit claiming that it paid kickbacks to US doctors to prescribe its multiple sclerosis drugs. That resulted in false claims for payment being submitted to the government healthcare programs Medicare and Medicaid, it alleged.
Let's personalize your content